Smoldering multiple myeloma: what is the current definition & new screening programme
MMRF updates from ASH 2017: CoMMpass study, transplant outcomes and the molecular profiling protocol
Are we ready for mutational directed treatment: addressing the genomic basis of myeloma
Gareth Morgan et al.
Smouldering myeloma: detection, risk stratification and defining a new standard of care
Benefits of early therapeutic intervention for high-risk smouldering multiple myeloma patients
Benefit of treating smouldering myeloma patients early with lenalidomide & dexamethasone